| 21.89 Data as of May 24 |  +0.23 / +1.06%Today’s Change | 16.19 Today|||52-Week Range 23.05 | +8.10% Year-to-Date |
| Previous close | 21.66 |
| Today’s open | 21.53 |
| Day’s range | 21.46 - 22.16 |
| Volume | 77,339 |
| Average volume (3 months) | 170,846 |
| Market cap | $907.7M |
| Dividend yield | 3.47% |
| Earnings growth (last year) | +23.08% |
| Earnings growth (this year) | +8.72% |
| Earnings growth (next 5 years) | +17.00% |
| Revenue growth (last year) | +8.65% |
| P/E ratio | 25.8 |
| Price/Sales | 4.54 |
| Price/Book | 6.33 |
| Today’s change | Today’s % change | |
|---|---|---|
| QDELQuidel Corp | +0.52 | +2.35% |
| GHDXGenomic Health Inc | 0.00 | 0.00% |
| DNDNDendreon Corp | -0.02 | -0.51% |
| NEOGNeogen Corp | +0.09 | +0.16% |
| Next reporting date | July 18, 2013 |
| EPS forecast (this quarter) | $0.22 |
| Annual revenue (last year) | $173.5M |
| Annual profit (last year) | $33.4M |
| Net profit margin | 19.23% |
Sector Health Technology |
Industry Biotechnology |
Executive Chairman William J. Motto |
CEO, Director & Head-Media Relations John A. Kraeutler |
Corporate headquarters Cincinnati, Ohio |
.
